Cannabidiol (CBD) is one of the most abundant cannabinoids in Cannabis Sativa, and the major chemical component of ‘light cannabis’ (<0.2% tetrahydrocannabinol and varying CBD content) [1], of which cultivation was recently decriminalised in the European Union [2] and the USA [3]. Isolated CBD is non-intoxicating and currently used in formulations for the treatment of epileptic seizures and multiple sclerosis. [...]
This paper was accepted for publication in the journal Clinical Chemistry and Laboratory Medicine (CCLM) published by Walter de Gruyter GmbH. The final publication is available at https://doi.org/10.1515/cclm-2023-0928.
Permission has been granted to share this article by Walter de Gruyter GmbH. All Rights Reserved.